Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC1A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DST - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NME6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSENEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MOV10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YBEY - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYMPK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MT1X - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IVD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRG-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKZF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PFDN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR2G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on